FHTX - Wall Street Estimates - Foghorn Therapeutics Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 4.525

-6.7 %

$ 252 M

Market Cap

-2.45

P/E

Price Target Average

209.39%

Revenue Forecast Estimate

25.53%

EBIT Estimate

27.85%

Net Income Estimate

28.15%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Foghorn Therapeutics Inc.

Wall Street analysts predict an average 1-year price target for FHTX of $14 , with forecasts ranging from a low of $9 to a high of $20 .

FHTX Lowest Price Target Wall Street Target

9 USD 98.90%

FHTX Average Price Target Wall Street Target

14 USD 209.39%

FHTX Highest Price Target Wall Street Target

20 USD 341.99%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free